Showing results (1871-1880 of 6,771) with videos related to

Sort By:
Pageof 678
Clinical Therapeutics|November 1, 1992
Reversal of the central effects of midazolam by intravenous flumazenil after general anesthesia and use of a long-acting opioid in hospitalized patients: report of a multicenter double-blind clinical study. The Flumazenil in General Anesthesia in Hospitalized Patients Study Group II
Clinical Therapeutics|July 16, 2003
Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United StatesKristen Migliaccio-Walle, Denis Getsios, J Jaime Caro, et al.
Clinical Therapeutics|July 16, 2003
Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care settingSalvatore Sapienza, Patricia Sacco, Kristine Floyd, et al.
Clinical Therapeutics|July 18, 2003
VoriconazoleLilyAnn Jeu, Frank J Piacenti, Aleksandr G Lyakhovetskiy, et al.
Clinical Therapeutics|July 18, 2003
Gabapentin dosing in the treatment of epilepsyMichael J McLean, Barry E Gidal
Clinical Therapeutics|July 18, 2003
The relationship between nonfasting and fasting lipid measurements in patients with or without type 2 diabetes mellitus receiving treatment with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitorsRobert Weiss, Melinda Harder, Jonathan Rowe
Clinical Therapeutics|August 30, 2003
Accurate diagnosis and appropriate treatment of acute bacterial rhinosinusitis: minimizing bacterial resistanceJavier Garau, Ron Dagan
Clinical Therapeutics|August 30, 2003
Tegaserod maleate in the treatment of irritable bowel syndrome: a clinical reviewAnastasia Rivkin
Clinical Therapeutics|August 30, 2003
A placebo-controlled comparison of ketotifen fumarate and nedocromil sodium ophthalmic solutions for the prevention of ocular itching with the conjunctival allergen challenge modelJack V Greiner, George Minno
Clinical Therapeutics|August 30, 2003
The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathyRoger A Rodby, Chion Fang Chiou, Jeff Borenstein, et al.
Pageof 678